NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis $12.98 -0.18 (-1.38%) Closing price 11/20/2026 03:59 PM EasternExtended Trading$13.25 +0.27 (+2.10%) As of 11/20/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About USANA Health Sciences Stock (NYSE:USNA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get USANA Health Sciences alerts:Sign Up Key Stats Today's Range$12.88▼$13.4350-Day Range$12.70▼$15.4852-Week Range$12.52▼$23.59Volume158,780 shsAverage Volume204,403 shsMarket Capitalization$239.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview USANA Health Sciences, Inc. develops and sells nutritional supplements, personal care products and foods. Its offerings include vitamins and other nutrition products, skincare products under the Celavive brand, and nutrition bars. Founded in 1992 by Myron Wentz, the company uses a direct-selling model, with independent Associates and other sales channels connecting its products with customers. USANA serves markets across North America, Asia-Pacific and other international regions.AI Generated. May Contain Errors. Read More USANA Health Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreUSNA MarketRank™: 0.94566425792 of 5 starsUSANA Health Sciences scored higher than 19% of companies evaluated by MarketBeat, and ranked 142nd out of 167 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.9 / 5Analyst RatingSell Consensus RatingUSANA Health Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 2 sell ratings.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 2 research reports in the past 90 days.Read more about USANA Health Sciences' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth127.27% Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 127.27% in the coming year, from $0.55 to $1.25 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is -11.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is -11.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 2.05. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.80% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 5.15.Change versus previous monthShort interest in USANA Health Sciences has recently increased by 12.86%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows1 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders0.82% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about USANA Health Sciences' insider trading history. Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. USNA Stock News HeadlinesUSANA Health Sciences (USNA) Stock Falls on Q3 2026 EarningsNovember 12, 2026 | quiverquant.comQUSANA Health Sciences FY2027 Earnings Forecast Cut by SidotiNovember 12, 2026 | americanbankingnews.comELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.November 21 at 1:00 AM | Paradigm Press (Ad)USANA Health Sciences Earnings Call Signals Mixed ProgressNovember 9, 2026 | tipranks.comUSANA Health Sciences, Inc. Updates Earnings Guidance for Fiscal Year 2026November 5, 2026 | marketscreener.comMUSANA (USNA) Q3 2026 Earnings Call TranscriptNovember 4, 2026 | finance.yahoo.comTranscript : USANA Health Sciences, Inc., Q3 2026 Earnings Call, Nov 04, 2026November 4, 2026 | marketscreener.comMUSANA expects net sales approaching $900M as it updates adjusted EBITDA outlook to approximately $77MNovember 4, 2026 | seekingalpha.comSee More Headlines USNA Stock Analysis - Frequently Asked Questions How have USNA shares performed this year? USANA Health Sciences' stock was trading at $19.61 at the beginning of the year. Since then, USNA stock has decreased by 33.8% and is now trading at $12.9780. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) issued its earnings results on Tuesday, November, 3rd. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.22. The company had revenue of $205.89 million for the quarter, compared to analyst estimates of $217.42 million. USANA Health Sciences had a positive trailing twelve-month return on equity of 3.56% and a negative net margin of 2.34%. Read the conference call transcript. Who are USANA Health Sciences' major shareholders? Top institutional investors of USANA Health Sciences include Pzena Investment Management LLC (6.03%), Nantahala Capital Management LLC (5.35%), State Street Corp (1.32%) and American Century Companies Inc. (1.01%). Insiders that own company stock include Myron W Wentz, Jim Brown, Kevin Guest, David Mulham Mulham, Frederic J Winssinger, John Turman Fleming, Peggie Pelosi, Walter Noot, Robert A Sinnott, Paul A Jones, Joshua Foukas, Gilbert A Fuller, G Doug Iiekking, Daniel A Macuga and Brent Neidig. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Nu Skin Enterprises (NUS), Procter & Gamble (PG), Herbalife (HLF), International Business Machines (IBM), Tesla (TSLA) and Best Buy (BBY). Company Calendar Last Earnings11/03/2026Today11/21/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 USNA's financial health is in the Red zone, according to TradeSmith. USNA has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Personal Care Products Sub-IndustryPersonal Care Products Current SymbolNYSE:USNA CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,570Year Founded1992Profitability EPS (Trailing Twelve Months)($1.15) Trailing P/E RatioN/A Forward P/E Ratio10.38 P/E Growth2.05Net Income$10.76 million Net Margins-2.34% Pretax Margin-0.01% Return on Equity3.56% Return on Assets2.62% Debt Debt-to-Equity RatioN/A Current Ratio2.59 Quick Ratio1.84 Sales & Book Value Annual Sales$925.26 million Price / Sales0.26 Cash Flow$3.96 per share Price / Cash Flow3.28 Book Value$28.49 per share Price / Book0.46Miscellaneous Outstanding Shares18,490,000Free Float18,337,000Market Cap$239.96 million OptionableOptionable Beta0.66 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NYSE:USNA) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.